[go: up one dir, main page]

CL2022002989A1 - Imidazopyridazines as modulators of il-17. - Google Patents

Imidazopyridazines as modulators of il-17.

Info

Publication number
CL2022002989A1
CL2022002989A1 CL2022002989A CL2022002989A CL2022002989A1 CL 2022002989 A1 CL2022002989 A1 CL 2022002989A1 CL 2022002989 A CL2022002989 A CL 2022002989A CL 2022002989 A CL2022002989 A CL 2022002989A CL 2022002989 A1 CL2022002989 A1 CL 2022002989A1
Authority
CL
Chile
Prior art keywords
imidazopyridazines
modulators
ameliorating
syndrome
disorder
Prior art date
Application number
CL2022002989A
Other languages
Spanish (es)
Inventor
Virginia Tanis
Steven Goldberg
Xiaohua Xue
John Keith
Douglas Behenna
Charlotte Deckhut
Alexander Rovira
David Kummer
Craig Woods
Timothy Rhorer
connor Martin
Steven Meduna
Stefan Mccarver
Alexander Valdes
Steven Loskot
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CL2022002989A1 publication Critical patent/CL2022002989A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente solicitud describe compuestos que tienen la siguiente fórmula: (I), o sales farmacéuticamente aceptables de estos, en donde R1 , R2 , R3 , R4 y R5 se definen en la especificación, así como métodos para elaborar y usar los compuestos descritos en la presente descripción para tratar o mejorar un síndrome, trastorno y/o enfermedad mediada por la IL-17.The present application describes compounds having the following formula: (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods for making and using the compounds described in the present disclosure for treating or ameliorating a syndrome, disorder and/or disease mediated by IL-17.

CL2022002989A 2021-04-30 2022-10-27 Imidazopyridazines as modulators of il-17. CL2022002989A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163017682P 2021-04-30 2021-04-30

Publications (1)

Publication Number Publication Date
CL2022002989A1 true CL2022002989A1 (en) 2023-04-28

Family

ID=86337478

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022002989A CL2022002989A1 (en) 2021-04-30 2022-10-27 Imidazopyridazines as modulators of il-17.

Country Status (1)

Country Link
CL (1) CL2022002989A1 (en)

Similar Documents

Publication Publication Date Title
CO2022017072A2 (en) Imidazopyridazines as modulators of il-17
DOP2024000051A (en) IMIDAZOPYRIDAZINE COMPOUNDS INHIBITORS OF IL-17
MX2022013650A (en) Imidazopyrimidines as modulators of il-17.
UY39957A (en) IMIDAZOPYRIDAZINE COMPOUNDS IL-17 INHIBITORS
CO2024000588A2 (en) Compositions and methods for ras inhibition
BR112023022580A2 (en) ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES
MX2020008024A (en) Indole carboxamides compounds useful as kinase inhobitors.
UY38670A (en) DIHYDROOROTATE DEHYDROGENASE INHIBITORS
MX2020010999A (en) MODULATORS OF METHYL MODIFIING ENZYMES, COMPOSITIONS AND THEIR USES.
MX2019008378A (en) PROCESS FOR THE SYNTHESIS OF AN INHIBITOR OF INDOLAMINE 2,3-DIOXYGENASE.
NI201500053A (en) ROR-GAMMA-T METHYLENE-LINKED QUINOLINYL MODULATORS
GT201500092A (en) ROR-GAMMA-T PHENYLED UNITED FINYLIN MODULATORS
EA202192433A1 (en) COMPOUNDS USEFUL IN HIV THERAPY
MX389545B (en) THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF SOCIAL DISORDERS AND SUBSTANCE USE DISORDERS.
EA202091597A1 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF SLEEP APNEA
MX2022006176A (en) COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR.
AR043444A1 (en) PROFARMACOS DE DIARIL-2- 5H -FURANONAS THAT RELEASE NITRIC OXIDE AS INHIBITORS OF CYCLLOXYGENASA-2
UY38304A (en) CYCLIC DINUCLEOTIDES AS STING AGONISTS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ECSP23091202A (en) TREX1 MODULATORS
CL2022002989A1 (en) Imidazopyridazines as modulators of il-17.
BR112022024700A2 (en) ATR INHIBITORS AND USES THEREOF
ECSP23088732A (en) TREX1 MODULATORS
CL2020001089A1 (en) Bruton's tyrosine kinase (btk) inhibitor compounds.
AR127149A1 (en) IMIDAZOPYRIDAZINE COMPOUNDS IL-17 INHIBITORS
MX2024012198A (en) COMPOUNDS AND METHODS FOR TREATING CANCERS